Search results for "Classification"

showing 10 items of 29475 documents

Changes in Self-Reported Physical Fitness, Performance, and Side Effects Across the Phases of the Menstrual Cycle Among Competitive Endurance Athletes

2019

Purpose: To investigate changes in self-reported physical fitness, performance, and side effects across the menstrual cycle (MC) phases among competitive endurance athletes and to describe their knowledge and communication with coaches about the MC. Methods: The responses of 140 participants (older than 18 y) competing in biathlon or cross-country skiing at the (inter)national level were analyzed. Data were collected via an online questionnaire addressing participants’ competitive level, training volume, MC history, physical fitness, and performance during the MC, MC-related side effects, and knowledge and communication with coaches about the MC and its effects on training and performance. …

medicine.medical_specialtymedia_common.quotation_subjectPhysical fitnessPhysical Therapy Sports Therapy and RehabilitationComputer-assisted web interviewingCoachingsex hormones03 medical and health sciences0302 clinical medicinecoachingPhysical fitness performanceMedicineOrthopedics and Sports MedicineNational levelLack of knowledgetraining quality030212 general & internal medicinevalmennusfemale athleteehkäisymenetelmätMenstrual cyclemedia_commonsukupuolihormonitbiologybusiness.industryAthletes030229 sport sciencesbiology.organism_classificationcoach educationPhysical therapyhormonal contraceptivesbusinessurheilijat
researchProduct

Trastornos del estado de ánimo al final de la vida: ¿desmoralización o depresión?

2008

This paper analyzes problems that result in an alteration of mood, particularly in the sadness found in people with a serious physical illness at the end of life. The problems and implications of an faulty diagnosis, the confusions associated with a diagnosis of depression, and the importance of differen-tiation between “normal” mood reactions to illness, and pathological reactions, are analyzed. Several studies are reviewed and analyzed that propose the incorporation of a new syndrome to the traditional psychiatric classifications: demoralization. Finally the implications, advantages, and inconveniences of including a demoralization syndrome are discussed.

medicine.medical_specialtymedia_common.quotation_subjectPsicologíaSadnessPsychiatry and Mental healthClinical PsychologyMoodPsychiatric ClassificationsmedicinePsychologyPsychiatryPathologicalPhysical illnessDepression (differential diagnoses)media_common
researchProduct

The incidence of infection, diagnosis and treatment of H. pylori in developing countries on the example of Kenya

2020

Machaj Dominik, Jastrzębska Sandra, Cyboran Katarzyna, Płaczek Alicja, Flaumenhaft Wiktoria. The incidence of infection, diagnosis and treatment of H. pylori in developing countries on the example of Kenya. Journal of Education, Health and Sport. 2020;10(3):11-17. eISSN 2391-8306. DOI http://dx.doi.org/10.12775/JEHS.2020.10.03.001 https://apcz.umk.pl/czasopisma/index.php/JEHS/article/view/JEHS.2020.10.03.001 https://zenodo.org/record/3696977 The journal has had 5 points in Ministry of Science and Higher Education parametric evaluation. § 8. 2) and § 12. 1. 2) 22.02.2019. © The Authors 2020; This article is published with open access at Licensee Open Journal Sy…

medicine.medical_specialtymedia_common.quotation_subjectRapid urease testEducationMedical microbiologyHygieneInternal medicineDiagnosismedicineInfection controlmedia_commonbiologyHelicobacter pyloribusiness.industryIncidence (epidemiology)RgastritisHelicobacter pyloribiology.organism_classificationLKenyaTreatmentGV557-1198.995MedicineGastritismedicine.symptombusinessDeveloped countrySportsJournal of Education, Health and Sport
researchProduct

Inequalities in the participation and outcomes of breast cancer screening programs in Valencia, Spain

2019

Abstract Background Breast cancer remains the most frequent tumour and first cancer related cause of death in the Valencian Community. Despite most of the population being aware of the existence of breast cancer screening programs (BCSP), there are great differences in uptake that are likely attributed to social determinants. The objective of this study, alligning with SDGs 3 and 10, is to assess inequalities in breast cancer screening uptake, diagnosis and treatment delay in the city of Valencia. Methods The population of study included 128 123 women invited to participate in the BCSP in the city of Valencia between 2014 and 2016. Uptake, diagnosis and treatment delay were assessed as outc…

medicine.medical_specialtymedicine.diagnostic_testbiologyInequalitybusiness.industrymedia_common.quotation_subjectPublic Health Environmental and Occupational Healthbiology.organism_classificationBreast cancer screeningFamily medicinemedicinebusinessValenciamedia_commonEuropean Journal of Public Health
researchProduct

On the diagnosis of human taeniasis by endoscopy

2010

medicine.medical_specialtymedicine.diagnostic_testbiologybusiness.industryGastroenterologymedicine.diseasebiology.organism_classificationEndoscopyDouble-balloon enteroscopymedicineTaeniasisTaeniaRadiology Nuclear Medicine and imagingRadiologybusinessGastrointestinal Endoscopy
researchProduct

Nitrate therapy: new aspects concerning molecular action and tolerance.

2011

Although the short-term vasodilatory properties of organic nitrates are potent and well known, a number of vascular and extravascular changes have been shown to compromise their hemodynamic effects on long-term administration. Among these changes, systemic phenomena such as neurohormonal activation and intravascular volume expansion1 as well as specific vascular changes such as increased vascular superoxide (O2·−) production,2 increased sensitivity to vasoconstrictors,3 and decreased responsiveness to nitric oxide (NO) donors4,5 have long been identified as playing a role. Several hypotheses have been proposed to explain these abnormalities, and over the last 15 years, our groups have focus…

medicine.medical_specialtymedicine.disease_causeNitric oxideSuperoxide dismutasechemistry.chemical_compoundPhysiology (medical)Internal medicineMedicineHumansEndothelial dysfunctionchemistry.chemical_classificationReactive oxygen speciesNitratesbiologybusiness.industrySuperoxideDrug Tolerancemedicine.diseaseNitric oxide synthaseOxidative StressEndocrinologychemistryCardiovascular Diseasesbiology.proteinEndothelium VascularCardiology and Cardiovascular MedicinebusinessPeroxynitriteOxidative stressCirculation
researchProduct

New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension deliver…

2018

COPD causes considerable health and economic burden worldwide, with incidence of the disease expected to continue to rise. Inhaled bronchodilators, such as long-acting muscarinic antagonists (LAMAs) and long-acting β2-agonists (LABAs), are central to the maintenance treatment of patients with COPD. Clinical studies have demonstrated that combined LAMA + LABA therapies improve efficacy while retaining a safety profile similar to LAMA or LABA alone. This has led to the development of several LAMA/LABA fixed-dose combination (FDC) therapies, which provide patients with the convenience of two active compounds in a single inhaler. GFF MDI (Bevespi Aerosphere®) is an FDC of glycopyrrolate/formote…

medicine.medical_specialtymedicine.drug_classDrug CompoundingFixed-dose combinationMuscarinic AntagonistsPulmonary Disease Chronic Obstructive03 medical and health sciences0302 clinical medicineFormoterol FumarateBronchodilatorAdministration InhalationmedicineHumans030212 general & internal medicineIntensive care medicineAdrenergic beta-2 Receptor AgonistsGlycopyrrolateCOPDbiologybusiness.industryInhalerGeneral MedicineLamamedicine.diseasebiology.organism_classificationGlycopyrrolateMetered-dose inhalerBronchodilator AgentsDrug CombinationsTreatment Outcome030228 respiratory systemFormoterolbusinesshormones hormone substitutes and hormone antagonistsmedicine.drugInternational Journal of Chronic Obstructive Pulmonary Disease
researchProduct

The role of fibrate treatment in dyslipidemia: an overview.

2012

Dyslipidemia, and especially atherogenic dyslipidemia, a combination of small low-density lipoproteins cholesterol (LDL-C), decreased high-density lipoprotein cholesterol (HDL-C) and increased triglyceride (TG) concentrations, represents a major cardiovascular (CV) risk factor. Nuclear receptor peroxisome proliferator-activated receptors (PPARs) are involved in the regulation of lipid metabolism; PPAR ligands are used to treat dyslipidemias. Fibrates have a major impact on TG metabolism as well as on modulating LDL size and subclasses. Fibrates target atherogenic dyslipidemia by increasing plasma HDL-C concentrations and decreasing small dense LDL (sdLDL) particles and TGs, thus contributin…

medicine.medical_specialtymedicine.drug_classPeroxisome proliferator-activated receptorAdipokineFibratechemistry.chemical_compoundInternal medicineDrug DiscoverymedicineAnimalsHumansTriglyceridesDyslipidemiasHypolipidemic AgentsPharmacologychemistry.chemical_classificationTriglycerideCholesterolbusiness.industryFibric Acidsnutritional and metabolic diseasesLipid metabolismCholesterol LDLmedicine.diseaseFibrates dyslipidemia cardiovascular risk diabetes.EndocrinologychemistryCardiovascular Diseaseslipids (amino acids peptides and proteins)Metabolic syndromebusinessDyslipidemiaCurrent pharmaceutical design
researchProduct

<p>Future perspectives of anticholinergics for the treatment of asthma in adults and children</p>

2019

Despite major advances in therapeutic interventions and the availability of detailed treatment guidelines, a high proportion of patients with symptomatic asthma remain uncontrolled. Asthma management is largely guided by the Global Initiative for Asthma (GINA) strategy and is based on a backbone of inhaled corticosteroid (ICS) therapy with the use of additional therapies to achieve disease control. Inhaled long-acting bronchodilators alone and in combination are the preferred add-on treatment options. Although long-acting muscarinic antagonists (LAMAs) are a relatively recent addition to disease management recommendations for asthma, tiotropium has been extensively studied in a large clinic…

medicine.medical_specialtymedicine.drug_classPsychological intervention030204 cardiovascular system & hematologyAsthma managementPlacebo03 medical and health sciences0302 clinical medicineAnticholinergicMedicinePharmacology (medical)030212 general & internal medicineGeneral Pharmacology Toxicology and PharmaceuticsDisease management (health)Intensive care medicineAsthmaChemical Health and Safetybiologybusiness.industryGeneral MedicineLamabiology.organism_classificationmedicine.diseaserespiratory tract diseasesClinical trialbusinessSafety ResearchTherapeutics and Clinical Risk Management
researchProduct

Selective RAR agonists for acne vulgaris: A narrative review.

2019

Background Acne vulgaris is a chronic disfiguring inflammatory disease of adolescents and adults affecting up to 90% of the population around the world. The sequence of etiopathogenesis in acne is not completely understood but involves abnormalities in sebum production, follicular plugging, proliferation of propionibacterium acnes, and chronic inflammation. Aims This review aims to summarize the features of the topical selective RAR agonists in treating acne vulgaris with a special emphasis on the 4th generation topical retinoid trifarotene. Methods Studies were identified by searching electronic databases (MEDLINE and PubMed) till August 2019 and reference lists of respective articles. Onl…

medicine.medical_specialtymedicine.drug_classReceptors Retinoic AcidPopulationTretinoinDermatologyAdministration Cutaneous030207 dermatology & venereal diseases03 medical and health sciencesPropionibacterium acnesRetinoids0302 clinical medicineMaintenance therapyTazaroteneAdapaleneAcne VulgarisMedicineHumansRetinoidAdapaleneeducationAcneRandomized Controlled Trials as Topiceducation.field_of_studybiologybusiness.industryNicotinic Acidsbiology.organism_classificationmedicine.diseaseDermatologyTreatment OutcomeTolerability030220 oncology & carcinogenesisDermatologic Agentsbusinessmedicine.drugJournal of cosmetic dermatologyREFERENCES
researchProduct